OLMETEC PLUS 20 mg / 12.5 mg Tablets (28 Tablets)
Active Ingredients:
Olmesartan Medoxomil 20 mg – Angiotensin II Receptor Blocker (ARB)
Hydrochlorothiazide 12.5 mg – Thiazide Diuretic
Therapeutic Class: Combination Antihypertensive
Dosage Form: Oral tablet
OLMETEC PLUS is indicated for:
Treatment of essential hypertension in patients whose blood pressure is not adequately controlled by olmesartan monotherapy
May also be used as substitution therapy in patients already receiving olmesartan and hydrochlorothiazide separately
Olmesartan blocks the angiotensin II type 1 (AT1) receptor, reducing vasoconstriction and aldosterone-mediated fluid retention, thereby lowering blood pressure
Hydrochlorothiazide increases sodium and water excretion by inhibiting reabsorption in the distal renal tubules, which helps reduce blood volume and pressure
The combination provides an additive antihypertensive effect through complementary mechanisms.
Recommended dose: One tablet once daily
Can be taken with or without food
Not intended as initial therapy
Dose adjustments may be needed based on clinical response
Contraindicated in pregnancy (especially second and third trimesters)
Use caution in patients with renal impairment, hepatic disease, electrolyte imbalance, or gout
Monitor renal function, serum potassium, and blood pressure during treatment
Common: dizziness, fatigue, increased urination, hypotension
Less common: hyperuricemia, electrolyte disturbances (e.g., hypokalemia), nausea, elevated creatinine
Store below 30°C in a dry place. Protect from moisture and light. Keep out of reach of children.